On this page
Menveo
Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Menveo
Proper name
Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine
Licence type
351(a)
BLA number
125300
Applicant
GlaxoSmithKline Biologicals
Center
CBER
Presentations
2
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 0.5ML | Injection | Intramuscular | Single-Dose Vial | Rx | February 19, 2010 |
| 0.5ML | Injection | Intramuscular | Single-Dose Vial | Rx | October 14, 2022 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |